Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1982 1
1984 1
1989 2
1990 1
1991 3
1992 7
1993 2
1994 2
1995 1
1996 2
1997 3
1998 3
1999 1
2000 7
2001 2
2002 2
2003 7
2004 5
2005 8
2006 4
2007 5
2008 7
2009 5
2010 8
2011 11
2012 11
2013 12
2014 15
2015 15
2016 13
2017 15
2018 12
2019 11
2020 14
2021 30
2022 22
2023 17
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

265 results

Results by year

Filters applied: . Clear all
Page 1
Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease.
Mulder K, Patel AA, Kong WT, Piot C, Halitzki E, Dunsmore G, Khalilnezhad S, Irac SE, Dubuisson A, Chevrier M, Zhang XM, Tam JKC, Lim TKH, Wong RMM, Pai R, Khalil AIS, Chow PKH, Wu SZ, Al-Eryani G, Roden D, Swarbrick A, Chan JKY, Albani S, Derosa L, Zitvogel L, Sharma A, Chen J, Silvin A, Bertoletti A, Blériot C, Dutertre CA, Ginhoux F. Mulder K, et al. Among authors: bertoletti a. Immunity. 2021 Aug 10;54(8):1883-1900.e5. doi: 10.1016/j.immuni.2021.07.007. Epub 2021 Jul 30. Immunity. 2021. PMID: 34331874 Free article.
SARS-CoV-2 immunity.
Bertoletti A. Bertoletti A. Cell Mol Immunol. 2024 Feb;21(2):101-102. doi: 10.1038/s41423-024-01128-y. Epub 2024 Jan 18. Cell Mol Immunol. 2024. PMID: 38238439 No abstract available.
Reply.
Kennedy PTF, Bertoletti A, Mason WS. Kennedy PTF, et al. Among authors: bertoletti a. Gastroenterology. 2017 Apr;152(5):1246-1247. doi: 10.1053/j.gastro.2017.03.002. Epub 2017 Mar 6. Gastroenterology. 2017. PMID: 28273438 No abstract available.
Editorial overview: Viral pathogenesis.
Bertoletti A, Iannacone M. Bertoletti A, et al. Curr Opin Virol. 2022 Aug;55:101253. doi: 10.1016/j.coviro.2022.101253. Epub 2022 Jul 8. Curr Opin Virol. 2022. PMID: 35810670 Free PMC article. No abstract available.
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
Le Bert N, Tan AT, Kunasegaran K, Tham CYL, Hafezi M, Chia A, Chng MHY, Lin M, Tan N, Linster M, Chia WN, Chen MI, Wang LF, Ooi EE, Kalimuddin S, Tambyah PA, Low JG, Tan YJ, Bertoletti A. Le Bert N, et al. Among authors: bertoletti a. Nature. 2020 Aug;584(7821):457-462. doi: 10.1038/s41586-020-2550-z. Epub 2020 Jul 15. Nature. 2020. PMID: 32668444
Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial.
Meng F, Zhao J, Tan AT, Hu W, Wang SY, Jin J, Wu J, Li Y, Shi L, Fu JL, Yu S, Shen Y, Liu L, Luan J, Shi M, Xie Y, Zhou CB, Wong RW, Lu-En W, Koh S, Bertoletti A, Wang T, Zhang JY, Wang FS. Meng F, et al. Among authors: bertoletti a. Hepatol Int. 2021 Dec;15(6):1402-1412. doi: 10.1007/s12072-021-10250-2. Epub 2021 Nov 30. Hepatol Int. 2021. PMID: 34850325 Free PMC article. Clinical Trial.
Fine-Tuning TLR-7-Based Therapy for Functional HBV Cure.
Bertoletti A, Le Bert N. Bertoletti A, et al. Hepatol Commun. 2019 Oct 1;3(10):1289-1292. doi: 10.1002/hep4.1420. eCollection 2019 Oct. Hepatol Commun. 2019. PMID: 31592063 Free PMC article.
Adaptive immunity in HBV infection.
Bertoletti A, Ferrari C. Bertoletti A, et al. J Hepatol. 2016 Apr;64(1 Suppl):S71-S83. doi: 10.1016/j.jhep.2016.01.026. J Hepatol. 2016. PMID: 27084039 Review.
265 results